Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biosimilar”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02921191
What this trial is testing

Descriptive Analysis of G-CSF Use in Patients With Breast Cancer, Lung Cancer, or Lymphoma Treated

Who this might be right for
Breast CancerLung Cancer
Biologics & Biosimilars Collective Intelligence Consortium 57,725
Not applicableUnknownNCT03729674
What this trial is testing

Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisUlcerative Colitis+1 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 800
Large-scale testing (Phase 3)Study completedNCT04058158
What this trial is testing

Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Samsung Bioepis Co., Ltd. 50
Large-scale testing (Phase 3)Study completedNCT04115488
What this trial is testing

Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Polpharma Biologics S.A. 265
Large-scale testing (Phase 3)UnknownNCT03952403
What this trial is testing

HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
CarcinomaNon-Small-Cell Lung
Shanghai Henlius Biotech 643
Post-approval studies (Phase 4)UnknownNCT02452151
What this trial is testing

"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"

Who this might be right for
Colitis, UlcerativeCrohn's Disease
Onze Lieve Vrouwe Gasthuis 300
Not applicableStudy completedNCT05716334
What this trial is testing

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

Who this might be right for
ANCA-associated VasculitisGranulomatosis With PolyangiitisMicroscopic Polyangiitis
McGill University Health Centre/Research Institute of the McGill University Health Centre 201
Large-scale testing (Phase 3)Active Not RecruitingNCT06687369
What this trial is testing

Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
mAbxience Research S.L. 726
Testing effectiveness (Phase 2)UnknownNCT03698383
What this trial is testing

Phase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerMetastatic Breast Cancer
Korean Cancer Study Group 15
Very early researchStudy completedNCT05663268
What this trial is testing

Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa

Who this might be right for
Hidradenitis Suppurativa
Services Institute of Medical Sciences, Pakistan 37
Large-scale testing (Phase 3)Study completedNCT03150589
What this trial is testing

Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular Degeneration
Samsung Bioepis Co., Ltd. 705
Not applicableLooking for participantsNCT06808685
What this trial is testing

Real World Multicenter National Study to Evaluate the Effectiveness and Safety of Biosimilar Bevacizumab Elovie

Who this might be right for
Metastatic Colorectal Cancer
Libbs Farmacêutica LTDA 133
Not applicableEnrolling By InvitationNCT04491721
What this trial is testing

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Chinese Academy of Medical Sciences 407
Early research (Phase 1)Study completedNCT06481202
What this trial is testing

A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers

Who this might be right for
Healthy Volunteers
AO GENERIUM 43
Large-scale testing (Phase 3)Study completedNCT01419665
What this trial is testing

GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)

Who this might be right for
Follicular Lymphoma
Sandoz 629
Not applicableStudy completedNCT05234021
What this trial is testing

HER2-directed Biosimilar in Breast Cancer: Real World ePRO

Who this might be right for
HER2-positive Breast CancerBiosimilarPatient Reported Outcome
OnkoZentrum Zürich AG 52
Early research (Phase 1)Study completedNCT04189484
What this trial is testing

Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors

Who this might be right for
Healthy SubjectsPharmacokineticsPharmacodynamics
Food and Drug Administration (FDA) 72
Early research (Phase 1)Study completedNCT06291948
What this trial is testing

A Clinical Study With Adalimumab Biosimilar

Who this might be right for
PharmacokineticsSafety Issues
Laboratorios Richmond S.A.C.I.F. 150
Large-scale testing (Phase 3)Study completedNCT04595409
What this trial is testing

Study to Compare the Efficacy, Safety, and Immunogenicity of the Proposed Biosimilar Ustekinumab FYB202 to Stelara® in Patients With Moderate-to-Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Bioeq GmbH 392
Large-scale testing (Phase 3)Study completedNCT02762955
What this trial is testing

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 344
Next Page